GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexstim Oyj (OHEL:NXTMH) » Definitions » EV-to-EBITDA

Nexstim Oyj (OHEL:NXTMH) EV-to-EBITDA : -38.64 (As of May. 30, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nexstim Oyj EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nexstim Oyj's enterprise value is €20.36 Mil. Nexstim Oyj's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.53 Mil. Therefore, Nexstim Oyj's EV-to-EBITDA for today is -38.64.

The historical rank and industry rank for Nexstim Oyj's EV-to-EBITDA or its related term are showing as below:

OHEL:NXTMH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -41.11   Med: -0.42   Max: 33.87
Current: -38.64

During the past 12 years, the highest EV-to-EBITDA of Nexstim Oyj was 33.87. The lowest was -41.11. And the median was -0.42.

OHEL:NXTMH's EV-to-EBITDA is ranked worse than
100% of 485 companies
in the Medical Devices & Instruments industry
Industry Median: 15.95 vs OHEL:NXTMH: -38.64

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-30), Nexstim Oyj's stock price is €2.75. Nexstim Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.200. Therefore, Nexstim Oyj's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nexstim Oyj EV-to-EBITDA Historical Data

The historical data trend for Nexstim Oyj's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexstim Oyj EV-to-EBITDA Chart

Nexstim Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.96 -44.65 30.46 14.30 -41.84

Nexstim Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.46 - 14.30 - -41.84

Competitive Comparison of Nexstim Oyj's EV-to-EBITDA

For the Medical Devices subindustry, Nexstim Oyj's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexstim Oyj's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexstim Oyj's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nexstim Oyj's EV-to-EBITDA falls into.



Nexstim Oyj EV-to-EBITDA Calculation

Nexstim Oyj's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=20.364/-0.527
=-38.64

Nexstim Oyj's current Enterprise Value is €20.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nexstim Oyj's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nexstim Oyj  (OHEL:NXTMH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nexstim Oyj's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.75/-0.200
=At Loss

Nexstim Oyj's share price for today is €2.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nexstim Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.200.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nexstim Oyj EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nexstim Oyj's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexstim Oyj (OHEL:NXTMH) Business Description

Traded in Other Exchanges
Address
Elimaenkatu 9 B, Helsinki, FIN, FI-00510
Nexstim Oyj is medical technology company. The company has developed a non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with 3D navigation providing accurate and personalized targeting of TMS to the specific area of the brain. The company earns revenue in Finland, Rest of Europe, North America and Other. The majority of revenue is earned in Finland.

Nexstim Oyj (OHEL:NXTMH) Headlines

No Headlines